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Over the past decade, the recognition and subsequent management of blunt cerebrovascular injuries has undergone a marked
evolution. Originally thought to be a rare occurrence, blunt cerebrovascular injuries are now diagnosed in approximately 1% of
blunt trauma patients. The recognition of a clinically silent period allows for angiographic screening for injuries based upon the
mechanism of trauma and the patient’s constellation of injuries. Comprehensive screening of patients has resulted in the early
diagnosis of blunt cerebrovascular injuries during the asymptomatic phase, thus allowing treatment that could prevent neurologic
sequelae. Although the ideal regimen of antithrombotic therapy is yet to be determined, treatment with either antiplatelet or
anticoagulant agents has been shown to reduce the blunt cerebrovascular injuries related stroke rate. Blunt cerebrovascular injury
is a rare but potentially devastating injury; appropriate angiographic screening in high-risk patients should be performed and
prompt treatment initiated to prevent ischemic neurologic events.
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Over the past decade, a wealth of studies has provided
the scientific rationale for promoting the early screening
and treatment of blunt cerebrovascular injuries (BCVI). Ini-
tially, BCVI were thought to have unavoidable, devastat-
ing neurologic outcomes, but several reports have suggested
that anticoagulant therapy improves neurologic outcome in
patients suffering ischemic neurologic events.1-7 If untreated,
carotid artery injuries (CAI) have a stroke rate up of to 50%
depending on the injury grade, with increasing stroke rates
correlated with increasing grades of injury; vertebral artery
injuries (VAI) have a stroke rate of 25%.3 Because many
of the patients with BCVI have concomitant traumatic brain
injuries, poor outcomes due to neurologic sequelae to BCVI
have been attributed to the traumatic brain injury. Screen-
ing protocols based on patient injury patterns and mecha-
nism of injury have been instituted prior to neurologic se-
quelae to identify these injuries in asymptomatic patients
and to initiate stroke-preventative treatment. Current stud-
ies suggest that early antithrombotic therapy in patients
with BCVI reduces stroke rates and prevents neurologic
morbidity.1,3,4,8–11
Historical Perspective
Blunt cerebrovascular injuries were first recognized
more than 30 years ago,12 but the majority of patients with
BCVI presented with symptoms of neurologic ischemia.12–16
The patient’s presenting symptom of cerebral ischemia may
reveal the underlying cerebrovascular injury. Carotid artery
injuries generally result in contralateral sensorimotor defi-
cits, while VAIs typically manifest as ataxia, dizziness,
vomiting, facial or body analgesia, or visual field defects.
Aphasia may be present if the dominant hemisphere is in-
volved, while nondominant hemisphere strokes may result
in hemineglect. Symptoms of carotid-cavernous fistulae in-
clude orbital pain, exophthalmos, chemosis, and conjunc-
tival hyperemia.
Crissey and Bernstein postulated 3 fundamental mecha-
nisms of injury: direct blow to the neck, hyperextension
with contralateral rotation of the head, and laceration of
the artery by adjacent fractures involving the sphenoid or
petrous bones.12 The most common mechanism causing
CAI is hyperextension resulting from the stretching of the
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carotid artery over the lateral articular processes of C1-
C3.13-18 Vertebral artery injuries are likely a combination
of direct injury, due to associated fractures of the verte-
brae involving the transverse foramen through which the
artery courses, and hyperextension-stretch injury due to the
tethering of the vertebral artery within the lateral masses
of the cervical spine. Regardless of mechanism, there is in-
timal disruption of the carotid or vertebral artery. This in-
timal tear becomes a nidus for platelet aggregation that may
lead to emboli or vessel occlusion.
Following the recognition that BCVI were responsible
for adverse neurologic events in some patients, treatment
modalities were debated. The vast majority of these lesions
occur in surgically inaccessible areas of the blood vessels,
either high within the carotid canal at the base of the skull
or within the foramen transversarium. Such a location
makes the standard vascular repair approaches including
reconstruction or thrombectomy challenging if not impos-
sible. Heparin was initially the treatment of choice for
BCVI, with the assumption that this promoted clot
stabilization if present and clot resolution through intrin-
sic fibrinolytic mechanisms, and it prevented further throm-
bosis.5,7,8 Treatment with anticoagulant agents has been
shown to improve neurologic outcome in patients sustain-
ing BCVI-related ischemic neurologic events (INE).5,7–9 Ini-
tial reports, including one of a multicenter study by the
Western Trauma Association, showed that patients who
were treated with anticoagulant agents had improved out-
come compared to those who were either not treated or had
a contraindication for anticoagulation due to associated
head injuries.5,7 In these studies, up to 45% of patients
achieved good neurologic status. The first single-institution
study with a large volume of experience demonstrated
heparin therapy was independently associated with survival
and improvement in neurologic outcomes.8 Follow-up
evaluations by other institutions support the use of antico-
agulation after the onset of neurologic symptoms to im-
prove overall functional outcome.4,9,19 Although the initial
focus of BCVI was recognizing the injury and treating the
devastating neurologic sequelae, subsequent efforts have
been directed at diagnosing and treating these injuries dur-
ing the “silent period,” prior to the onset of stroke.
BCVI Screening during the “Silent Period”
Although some patients may present with symptoms
within an hour of injury, the majority exhibit a latent pe-
riod. This asymptomatic phase has been inferred based
upon the time to onset of symptoms in patients who did
not receive antithrombotic therapy. This time frame appears
to range from hours up to 14 years, but the majority of
patients seem to develop symptoms within 10 to 72
hours.3-5,17,18,20,21 Diagnosing BCVI during this “silent pe-
riod” affords the opportunity for treatment prior to neuro-
logic sequelae.
Aggressive screening for BCVI was initially suggested
in the mid-1990s8,9 after recognition that specific patterns
of injuries were associated.5,7,22 Although optimal screening
criteria are yet to be defined, current algorithms include
patients with signs or symptoms, as well as those consid-
ered at high risk by the injury pattern1,4,11,18 (Table 1). A
recently published report questioned the utility of such an
aggressive screening approach,23 while other studies have
reported a screening yield of over 30% in high-risk
populations.1,2,4,11,24
Diagnostic Imaging and Injury Grading Scale
Until the sensitivity and specificity of computed tomo-
graphic angiography (CTA) or magnetic resonance angiog-
raphy (MRA) approaches that of angiography, 4-vessel ar-
teriography remains the gold standard for diagnosing BCVI.
Undoubtedly, many clinicians question the need for subject-
ing patients to angiography. Angiography is labor intensive,
costly, and not without risks; additionally, if not available
at smaller hospitals, it requires emergent transfer of a pa-
Table 1- Denver screening criteria for blunt cerebrovascular
injury (BCVI)
Signs/Symptoms of BCVI
Arterial hemorrhage
Cervical bruit in patient < 50 years of age
Expanding cervical hematoma
Focal neurologic deficit
Neurologic exam incongruous with head CT scan findings
Stroke on secondary CT scan
Risk Factors for BCVI
High-energy transfer mechanism with:
LeForte II or III fracture
Cervical-spine fracture patterns: subluxation, fractures extending into the
transverse foramen, fractures of C1-C3
Basilar skull fracture with carotid canal involvement
Diffuse axonal injury with a Glascow Coma Scale (GCS) score < 6
Near hanging with anoxic brain injury
Table 2 - Denver grading scale for blunt cerebrovascular
injuries
Grade I: irregularity of the vessel wall or a dissection/intramural
hematoma with less than 25% luminal stenosis
Grade II: intraluminal thrombus or raised intimal flap is visualized, or
dissection/intramural hematoma with 25% or more luminal
narrowing
Grade III: pseudoaneurysm
Grade IV: vessel occlusion
Grade V: vessel transection
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tient for definitive evaluation. Currently, CTA remains an
unproven diagnostic modality for this injury, with a sensi-
tivity of between 50% to 68%.2,3,25 In particular, injuries that
may be missed by such noninvasive studies are typically
grade I and II injuries; however, pseudoaneurysms and oc-
clusions have also been misdiagnosed.2,3 The risk associated
with angiography in our screened trauma population was
0.1%, while the stroke risk for an undiagnosed grade I CAI
is 8% and of VAI is 6%.3,4 While advances in technology
with improved imaging by multislice CT scanners may be-
come an alternative in the future, until these modalities are
evaluated with follow-up angiography, standard 4-vessel an-
giography remains the standard of care.
All patients with indications for screening and no
contraindications for antithrombotic therapy undergo angi-
ography as soon as possible. In our institution, patients ad-
mitted during daytime hours undergo angiography prior to
transport to the surgical intensive care unit from the emer-
gency department unless an urgent operation intervenes; pa-
tients evaluated after daylight hours undergo angiography the
morning following admission. If the patient is symptomatic
on admission, emergent angiography is performed.
Along with the recognition of varied luminal irregulari-
ties comprising BCVI (dissection, occlusion, transection,
and pseudoaneurysms) was the identification of disparate
outcomes.5,8 An injury grading scale was developed18 to pro-
vide not only an accurate description of the injury, but also
to define stroke risk by injury grade. Untreated injuries have
an overall stroke rate of 21% to 64%,1,11 CAIs have increas-
ing stroke rate by increasing grade, and VAIs tend to have
a more consistent stroke rate of approximately 20% for all
grades of injury3 (Table 3). Figure 1 shows representative
angiographic images of different grades of BCVI.
Patients undergo repeat arteriography 7 to 10 days af-
ter their initial diagnostic study. The importance of rou-
tine follow-up arteriography is particularly salient for pa-
tients with grade I and II injuries; over half of grade I in-
juries completely heal, allowing cessation of antithrombotic
therapy.3 While only 8% of grade II injuries healed in this
study, over 40% progressed to grade III injuries despite
therapy; in patients with CAI, this increase in injury grade
Table 3 - Stroke rate by blunt cerebrovascular injury grade
Grade of injury Stroke rate
Carotid artery injuries I 3%
II 14%
III 26%
IV 50%
V 100%
Vertebral artery injuries I 6%
II 38%
III 27%
IV 28%
V 100%
Figure 1 - Representative angiographic images of different grades of BCVI
Injury Grade: Angiographic Finding; Grade I: Intimal Irregularity, <25% Luminal Stenosis; Grade II: Intimal Irregularity, >25% Luminal Stenosis, Intimal
Flap; Grade III: Pseudoaneurysm; Grade IV: Occlusion; Grade V: Transection with active extravasation.
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also correlates with an increase in stroke risk. Some au-
thors have advocated an endovascular approach to
pseudoaneurysms, hence supporting the use of repeat an-
giography for diagnosis of such lesions. Our most recent
evaluation of endovascular stents in patients with postinjury
BCVI, however, suggests that antithrombotic therapy re-
mains the gold standard treatment.10 Patients with carotid
or vertebral artery occlusions may not require reimaging,
as 82% showed no change on follow-up imaging.3
Treatment: Antithrombotics
Initially, therapy for BCVI was based on anecdotal re-
ports of neurologic improvement with heparinization in
patients suffering stroke related to BCVI.5,7,8 Subsequently,
intravenous heparin was thought to be the treatment of
choice for those asymptomatic patients with blunt inju-
ries.2,3 Initially, standard heparinization protocols were used,
but due to a moderate incidence of bleeding in multisystem
trauma patients, we modified our protocol.9,18 Currently,
anticoagulation with systemic heparin is initiated using a
continuous infusion of heparin at 15 U/kg/h, without a load-
ing dose; heparin drips are titrated to achieve a partial
thromboplastin time (PTT) of between 40 and 50 seconds.
With this adjustment in our BCVI heparin protocol, fewer
than 1% of patients have had bleeding complications ne-
cessitating transfusion.4 For patients with contraindications
for heparin, the initiation of antiplatelet agents (aspirin 325
mg/d and clopidogrel 75 mg/d) has gained favor.3,21,26 It
should be noted that antithrombotic therapy is not started
with patients having closed head injury or intraparenchymal
hemorrhage without input from the neurosurgery service.
Admittedly, there is controversy regarding the ideal
antithrombotic therapy—anticoagulant versus antiplatelet
agents—for any type of arterial disease.27-29 A retrospective
study by Chimowitz et al30 indicated that warfarin is supe-
rior in patients with vertebrobasilar occlusive disease, while
a more recent prospective double-blind comparison by the
same authors demonstrated aspirin is the therapy of choice
for patients with symptomatic intracranial atherosclerotic
arterial stenosis, due to equivalent stroke prevention rates as
for warfarin, but decreased hemorrhagic complications.30 A
recent review of vertebrobasilar disease supported the use
of antiplatelet agents in patients with arterial stenosis but
warfarin in patients with severe, flow-limiting lesions or dis-
sections.31 The selection of which therapeutic agent should
be used and whether the choice of antithrombotic should be
determined by the patient’s injury grade must continue to
be evaluated in prospective studies.
Most importantly, patients who are diagnosed early and
treated with antithrombotics almost universally avoid INE.2,4
The Memphis group showed a reduction in stroke rate for CAI
from 64% in untreated patients to 6.8% in treated patients (ei-
ther with anticoagulant or antiplatelet agents), and for VAI a
reduction in stroke rate from 54% to 2.6% in untreated ver-
sus treated patients. Our group’s most recent evaluation dem-
onstrated a stroke rate of 0.5% in 187 patients with BCVI
treated with antithrombotics, while untreated patients had an
overall stroke rate of 21%.10 Although the optimal regimen
remains undetermined, there appears to be equivalence be-
tween the two therapies.2–4 To determine the ideal therapeutic
regimen for BCVI, we are currently enrolling patients in a
prospective randomized study comparing antiplatelet agents
to intravenous heparin in patients with grades I to III injuries.
With an attendant permanent neurologic morbidity of up to
80% and mortality rates of up to 40%,20,32,33 prompt treatment
of diagnosed injuries is critical.
Treatment: Endovascular Stents
Over the past decade, there has been an explosion in the
use of percutaneous transluminal arterial interventions for
both traumatic injuries and atherosclerotic lesions. Although
the role of carotid stents for atherosclerotic disease is being
explored with randomized, well-controlled trials,34-37 the in-
dication for percutaneous intervention for traumatic injuries
is less well defined. Carotid stents have been utilized in pa-
tients with blunt injury with persistent pseudoaneurysms be-
cause of concern about subsequent embolization or rup-
ture.38,39 In theory, the uncovered carotid stent acts as a fil-
ter to trap any thrombus within the pseudoaneurysm, thereby
preventing subsequent embolization and stroke. The stent
may also decrease flow into the pseudoaneurysm by increas-
ing laminar flow within the stented portion of the carotid
lumen itself.40 Decreasing flow into the aneurysmal sac may
then reduce any egress of blood from the sac, which in turn
may reduce turbulence within the lumen.
Several isolated case reports have advocated the use of
percutaneous angioplasty and stenting of carotid injures.41-47
Not surprisingly, these case reports represent a diverse
range of pathologies, symptoms, mechanisms of injury, and
time to diagnosis. Although the majority appears to have
patency of the stented carotid artery documented in follow-
up radiographic evaluations, several cases of carotid artery
occlusion following stent placement have been reported.42,44
Our most recent evaluation indicates a prohibitive stroke
and carotid occlusion rate associated with carotid stents
placed in acutely injured vessels11; additionally, long-term
follow-up in patients with traumatic pseudoaneurysms who
were treated with anticoagulant therapy alone has not been
evaluated. Further understanding and evaluation of the role
of appropriate concurrent antithrombotic therapy, as well
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as evolving stent technology including smaller delivery sys-
tems and covered stents, may improve the outcome for
postinjury intraluminal carotid stents. In the interim, how-
ever, our experience to date suggests that carotid stenting
should be performed in selective cases, and antithrombotic
therapy should remain the cornerstone of treatment for
posttraumatic pseudoaneurysms.
Long-Term Treatment and Outcomes
Following initiation of antithrombotics, treatment is
empirically continued for 6 months. Our current protocol
is to transition the patient to warfarin if the initial
antithrombotic therapy was heparin, with a goal INR (in-
ternational normalized ratio) of 2.0. If the patient was
started on antiplatelet agents, these are continued after hos-
pital discharge. Although complete healing of grade I in-
juries on repeat angiography at 7-10 days has been docu-
mented in more than half of affected patients, the vast ma-
jority of grade II, III, and IV injuries persist. Comprehen-
sive long-term follow-up beyond the acute hospitalization
has not been reported in the literature, as is true in most
trauma population studies. Therefore, whether these inju-
ries heal or persist at 3 to 6 months is unknown. There are
anecdotal reports of carotid pseudoaneurysm rupture, par-
ticularly in the petrous portion of the canal leading to
epistaxis.48-53 However, aside from these limited cases lo-
cated intracranially, few other reports are evident in the lite-
rature.54,55 With so little long-term data, it is difficult to as-
certain either the true healing rate of these injuries or the
risk of rupture or embolic stroke.
The morbidity and mortality of BCVI-related INEs is
well documented. Stroke-related need for discharge and
overall rate of discharge to rehabilitation services is higher
in patients suffering BCVI-related INE.10 Such prolonged
acute patient care increases costs to patients, to insurance
companies, and ultimately to society. Although delineat-
ing the precise BCVI-related costs within a patient’s acute
or rehab stay is difficult in multisystem trauma patients,
calculating the cost of a patient’s life is even more prob-
lematic. is even more problematic. Mortality due to BCVI
is significant, with CAI patients having a 13% to 21%
stroke-related mortality and patients with VAI-related
strokes having a 4% to 18% mortality rate in modern se-
ries.1,11 The impact on mortality due to BCVI-related
strokes appears independent of the patient’s associated in-
juries. Overall mortality in patients sustaining CAI was 7%
for those without a neurologic event versus 32% for those
with a neurologic event; in patients with VAI, those with-
out neurologic event had a mortality of 7% while those with
a neurologic event had a mortality rate of 18%; the ISS
(illness severity scale) was not significantly different be-
tween those with and without INE.10
Repeat evaluation of the patient’s injury and a deter-
mination of antithrombotic therapy should be considered
at 6 months. Although no long-term studies have been per-
formed to date, we currently recommend CTA for patients
with initially diagnosed grade III and IV injuries, and an-
giography for grade I and II injuries. If the patient does
not wish to undergo angiography with its attendant risks,
we empirically consider placing the patient on life-long as-
pirin. Similarly, patients with persistent grade III and IV
injuries on repeat imaging are empirically continued on
life-long aspirin.
CONCLUSIONS
Diagnosis and treatment of blunt cerebrovascular inju-
ries has evolved over the past 3 decades. Currently,
protocols exist for establishing an indication for
angiographic screening based on the injury mechanism and
associated injuries,7 hence limiting invasive procedures to
those with the highest risk of injury (Figure 2). Following
identification of injuries in asymptomatic patients, prompt
initiation of antithrombotic therapy reduces the incidence
of ischemic neurologic events. Surgeons caring for the mul-
tiply injured should screen for carotid and vertebral artery
injuries in high-risk patients.
Figure 2 -  Denver screening and treatment algorithm for BCVI
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